Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril in pediatric Alport syndrome
NCT01485978Phase 3Completed
- Sponsor
- Institut für anwendungsorientierte Forschung und klinische Studien
- Start
- Mar 2012
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramipril in Alport syndrome, sponsored by Institut für anwendungsorientierte Forschung und klinische Studien. Started Mar 2012; status: completed.
02
Drugs
ramipril
03
Conditions
Alport syndrome
Beyond the preview
Go deeper on NCT01485978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01485978.